Forest Labs To Settle Shareholders' Suit For $65M
Forest Laboratories Inc. has reached a tentative settlement of $65 million in a securities class action that claimed the company provided misleading information about the safety of its blockbuster antidepressants, Celexa...To view the full article, register now.
Already a subscriber? Click here to view full article